IceCure Medical Ltd.
(NASDAQ: ICCM)
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
0.690
+0.011
(+1.62%)
Range
0.680 - 0.734
(7.94%)
Open
0.695
Previous Close
0.679
Bid Price
1.140
Bid Volume
10
Ask Price
1.160
Ask Volume
11
Volume
729,069
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 01:57.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
